Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

FDC LTD. - 531599 - US - FDA Inspection At Company'S Manufacturing Facility Located At Waluj, Aurangabad.

 This is to inform you that our manufacturing plant located at B-8, MIDC Industrial Area, Waluj, Aurangabad, Maharashtra, which manufactures sterile ophthalmic products, has been inspected by US FDA from 06th February to 12th February 2023. The said audit has been successfully completed by the US FDA with 'No observations' (Zero 483's). The audit was carried out for the sterile ophthalmic products being marketed in the US.
13-02-2023

FDC Consolidated December 2022 Net Sales at Rs 409.30 crore, up 19.75% Y-o-Y

 NULL
10-02-2023
Bigul

Q3FY23 Quarterly Result Announced for FDC Ltd.

 Pharmaceutical firm FDC announced Q3FY23 results: Consolidated Q3FY23 and 9MFY23: India Market: The sale of branded formulations in India for Q3FY23 was Rs 318 crore, with a growth of 10.2% on YoY and -14.1% on QoQ. Overall sales in the Indian market accounted for 78% of total consolidated sales for the quarter. For 9MFY23 sales were at Rs 1,109 crore, growth of 8.1% over the same period last year. As per secondary sales data by IQVIA for the quarter that ended Dec 31, 2022, the company delivered strong YoY growth of 17.5% compared to the Indian Pharmaceutical Market (IPM) growth of 10.0% YoY. Export Formulations Market: Formulation sales in the export market were Rs 72 crore in Q3FY23, up by 84.2% over YoY and up by 24.6% over QoQ, accounting for 17% of total consolidated sales. For 9MFY23 sales were Rs 185 crore, up by 55.3% over the same period last year. The main contributor is the USA market, accounting for 47% of total export formulations sales. Export API Market: API sales in the export market were Rs 20 crore in Q3FY23, up by 37.4% over YoY and accounted for 5% of total consolidated sales. For the 9MFY23, sales were Rs 55 crore, up by 31% over the same period last year. Result PDF
10-02-2023
Bigul

FDC LTD. - 531599 - Announcement under Regulation 30 (LODR)-Investor Presentation

 FDC Limited has informed the Exchange about Investor Presentation.
09-02-2023
Bigul

FDC LTD. - 531599 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Please find attached herewith the Press Release issued in relation to the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2022.
09-02-2023
Bigul

FDC LTD. - 531599 - Financial Results For The Period Ended December 31, 2022

 Quarterly and nine months ended Financial Results For The Period Ended December 31, 2022
09-02-2023
Bigul

FDC LTD. - 531599 - Board Meeting Outcome for Outcome Of Board Meeting Held On February 09, 2023

 This is to inform that the Board of Directors at its meeting held on Thursday, February 09, 2023 has approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2022 along with the Limited Review Report as given by the Statutory Auditors of the Company.
09-02-2023
Bigul

FDC LTD. - 531599 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Company has issued a Duplicate Share Certificate in lieu of the original Share Certificate reported lost/misplaced. We have completed the process for issue of duplicate share certificate through Registrar & Share Transfer Agent (RTAs).
08-02-2023
Bigul

FDC LTD. - 531599 - Board Meeting Intimation for Intimation Of Board Meeting & Closure Of The Trading Window

 FDC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2023 ,inter alia, to consider and approve the Unaudited Financial Results along with the Limited Review Report of the Company for the quarter ended December 31, 2022. Further, in accordance with Code of Conduct adopted by the Company, SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018 and vide our Intimation letter dated December 28, 2022, the Trading Window of the Company has been closed for all the Designated Persons, Connected Persons and their Immediate Relatives from Sunday, January 01, 2023, till 48 hours after the declaration of Unaudited Financial Results for the quarter ended December 31, 2022.
31-01-2023
Bigul

FDC LTD. - 531599 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Please find enclosed the certificate issued by the Registrar and Share Transfer Agent of the Company i.e. Link Intime India Pvt. Ltd., regarding the details of the securities dematerialized /rematerialized during the quarter ended on December 31, 2022 as required under regulation 74 (5) of the SEBI (Depositories and Participants) Regulation, 2018.
07-01-2023
Next Page
Close

Let's Open Free Demat Account